CORDIS LAUNCHES PALMAZ BLUE STENT IN U.S.
Cordis Endovascular, a Johnson & Johnson subsidiary, launched the Palmaz Blue Transhepatic Biliary Cobalt Chromium Stent in the U.S.
Featuring L605, a cobalt alloy enhanced with tungsten, the Palmaz Blue balloon-expandable stent technology is stronger than stainless steel stents and uses less metal. It is designed to provide physicians with increased strength, radiopacity, low profiles, and superior flexibility and deliverability.
The stent features a closed cell design, tapered radial arcs, optimized struts and double Omega hinges -- designed to optimize fatigue life, maximize radial strength and minimize foreshortening. The product is currently available in a .018 over-the-wire system in 4-7 mm expansion diameter and 12, 15, 18 and 24 mm lengths.